Currently Enrolling Inpatient
Zika 316 Inpatient Study

Summary

The purpose of this study is to evaluate the clinical and virologic response to escalating doses of 2 different Zika virus strains. The study is recruiting 18-40 year old FEMALES ONLY and involves:

  • At least 2 screening visits
  • 16 day inpatient stay
  • 11 outpatient follow-up visits following discharge
  • Use of effective birth control for duration of the study
  • Up to $4610 for study participation
  • Screening at Hampton House and Bayview

Complete the CIR Contact Form

Screening Dates
CIR Hampton House and Bayview in-person screening dates coming soon!


Screening Location
CIR Outpatient Clinic
Hampton House Rm. 117
Baltimore, MD 21205

and

CIR Inpatient Unit at Bayview
301 Building, 4th Floor
301 Mason Lord Drive
Baltimore, MD 21224
Study Period
6 months long following inoculation

Compensation
Up to $4610 for completion of all study procedures

Complete the CIR Contact Form